XTL Biopharmaceutica (Israel) Management Performance Evaluation

XTLB -- Israel Stock  

ILS 9.80  0.20  2.08%

Analysis of XTL Biopharmaceutica manpower and management performance can provide insight into XTL Biopharmaceutica stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with XTL Biopharmaceuticals future performance. See also Your Current Watchlist.
Symbol  XTLB
Name  XTL Biopharmaceuticals Ltd
TypeStock
Country   Israel
Exchange  Tel Aviv

Information on XTL Biopharmaceuticals Ltd Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out.

Currently Trending

IIPR   
Purchased over 100 shares of
a day ago
Traded for 41.84
USOI   
Purchased over 100 shares of
a day ago
Traded for 28.79
MSFT   
Purchased over 100 shares of
a day ago
Traded for 108.66
MLPB   
Purchased over 100 shares of
a day ago
Traded for 23.66
MAYS   
Purchased over 100 shares of
a day ago
Traded for 39.68

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

XTL Biopharmaceutica Management Effectiveness

The company has return on total asset (ROA) of (9.81) % which means that it has lost $9.81 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 22.08 % meaning that it generated $22.08 on every $100 dollars invested by stockholders.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add XTL Biopharmaceuticals Ltd to your portfolio
See also Your Current Watchlist. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Search macroaxis.com